Literature DB >> 16405934

A cytokine promoter/yellow fluorescent protein reporter transgene serves as an early activation marker of lymphocyte subsets.

Shantha Kumar1, Marianne J Skeen, Yaffa Adiri, Hyseuk Yoon, Vaiva D Vezys, Aron E Lukacher, Brian D Evavold, H Kirk Ziegler, Jeremy M Boss.   

Abstract

A mouse containing an IL-4 promoter linked to the yellow fluorescent protein (YFP) reporter transgene was created to follow aspects of lymphocyte development and function. Following stimulation with phorbol 12-myristate 13-acetate and ionomycin, anti-CD3/CD28, antigen-specific peptide, or allogeneic cells, both CD4 and CD8 T cells expressed the transgene within 24h in a manner that was consistent with cellular activation markers. Transgene induction was inhibited by cyclosporine and FK506, suggesting that its activation occurs in an NFAT-dependent manner. B lymphocytes were also able to express the transgene when stimulated with LPS. This induction was inhibited in part by rapamycin. The results suggest that this transgene can function as an indicator of lymphocyte activation. Because YFP is not toxic and requires no preparation of the cells to view the reporter gene, this system provides a unique tool to follow lymphocyte activation in a number of model systems, such as those involving transplantation, allergy, and vaccine development.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16405934     DOI: 10.1016/j.cellimm.2005.11.003

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  4 in total

Review 1.  Cytokine reporter mice in immunological research: perspectives and lessons learned.

Authors:  Andrew L Croxford; Thorsten Buch
Journal:  Immunology       Date:  2010-11-11       Impact factor: 7.397

2.  Noninvasive imaging of cell-mediated therapy for treatment of cancer.

Authors:  Elizabeth J Akins; Purnima Dubey
Journal:  J Nucl Med       Date:  2008-06       Impact factor: 10.057

3.  Tumor-infiltrating lymphocytes in primary tumors of colorectal cancer and their metastases.

Authors:  Katarzyna Jakubowska; Mariusz Koda; Wojciech Kisielewski; Luiza Kańczuga-Koda; Waldemar Famulski
Journal:  Exp Ther Med       Date:  2019-10-30       Impact factor: 2.447

Review 4.  Cellular based treatment modalities for unresectable hepatocellular carcinoma.

Authors:  Konstantinos Damiris; Hamza Abbad; Nikolaos Pyrsopoulos
Journal:  World J Clin Oncol       Date:  2021-05-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.